HMGA2 expression and response to anthracycline-based preoperative chemotherapy in patients with operable breast cancer

Authors :: M. Mansutti
V. Giancotti
C. Di Loreto
Federica Edith Pisa
Maura Pandolfi
Paola Ermacora
Pamela Driol
B. Alessi
P. Masolini
Fabio Puglisi
Source :: Journal of Clinical Oncology. 26:22035-22035
Publication Year :: 2008
Publisher :: American Society of Clinical Oncology (ASCO), 2008.
Abstract: 22035 Background: Preclinical data suggest that increased expression of high mobility group A2 (HMGA2) protein could enhance chemosensitivity towards doxorubicin in breast cancer cells. The present...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
biology
Anthracycline
business.industry
medicine.disease
Preclinical data
Breast cancer
HMGA2
Internal medicine
medicine
biology.protein
Preoperative chemotherapy
Doxorubicin
In patient
Breast cancer cells
business
medicine.drug

Full Text Access

Tools